A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT03859427 · COMPLETED
Trial details
- NCT number
- NCT03859427
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-08
- Primary completion
- 2023-03-31
- Enrollment
- 454
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.